Novel Assay System Favorable for the Study of Cell-to-Cell Transmission of HIV-1 and Its Application to the Evaluation of Anti-HIV Drugs
Biological and Pharmaceutical Bulletin Volume 18 Issue 6
Page 920-922
published_at 1995-06-15
アクセス数 : 539 件
ダウンロード数 : 193 件
今月のアクセス数 : 6 件
今月のダウンロード数 : 4 件
この文献の参照には次のURLをご利用ください : https://ir.lib.hiroshima-u.ac.jp/00047049
File |
BiolPhamBull_18_920.pdf
548 KB
種類 :
fulltext
|
Title ( eng ) |
Novel Assay System Favorable for the Study of Cell-to-Cell Transmission of HIV-1 and Its Application to the Evaluation of Anti-HIV Drugs
|
Creator |
Inoue Yoshio
Kanamori Tatsuyuki
Fujimoto Yasuhiro
Yoshida Tetsuya
|
Source Title |
Biological and Pharmaceutical Bulletin
|
Volume | 18 |
Issue | 6 |
Start Page | 920 |
End Page | 922 |
Abstract |
The cell-to-cell transmission of human immunodeficiency virus type 1 (HIV-1) was studied using MOLT-4 cells chronically infected with a variant strain of HIV-1SF-2 (MOLT-4/HIV-1SF-2H) and CD4+ human lymphoid MT-4 cells. MOLT-4/HIV-1SF-2H cells produced less than 1 TCID50 infectious particles per 105 cells per day as determined by the cytopathogenicity in MT-4 cells. However, the expression of envelope glycoproteins gp120 and gp41 on the MOLT-4/HIV-1SF-2H cell membrane was satisfactory for syncytium formation with the uninfected MOLT-4 cells. When MOLT-4/HIV-1SF-2H and MT-4 cells were co-cultured, severe cytopathogenicity was observed in MT-4 cells without being accompanied by the formation of multi-nucleated cells. Thus, the system consisting of MOLT-4/HIV-1SF-2H and MT-4 cells is convenient for exclusive study of the mechanism of cell-to-cell transmission of HIV-1. Using various compounds, it was confirmed that cell-to-cell transmission required both gp120/gp41-CD4 binding and de novo DNA synthesis.
|
Keywords |
human immunodeficiency virus
cell-to-cell transmission
syncytium formation
de novo DNA synthesis
|
NDC |
Medical sciences [ 490 ]
|
Language |
eng
|
Resource Type | journal article |
Publisher |
The Pharmaceutical Society of Japan
|
Date of Issued | 1995-06-15 |
Rights |
© 1995 Pharmaceutical Society of Japan
|
Publish Type | Version of Record |
Access Rights | open access |
Source Identifier |
[ISSN] 0918-6158
[ISSN] 1347-5215
[NCID] AA10885497
[DOI] 10.1248/bpb.18.920
[DOI] https://doi.org/10.1248/bpb.18.920
|